- Home
- AYTU vs FCUV Comparison
AYTU vs FCUV Comparison
Compare AYTU & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYTU
- FCUV
- Stock Information
- Founded
- AYTU N/A
- FCUV 2012
- Country
- AYTU United States
- FCUV United States
- Employees
- AYTU N/A
- FCUV N/A
- Industry
- AYTU Biotechnology: Pharmaceutical Preparations
- FCUV Industrial Machinery/Components
- Sector
- AYTU Health Care
- FCUV Industrials
- Exchange
- AYTU Nasdaq
- FCUV Nasdaq
- Market Cap
- AYTU 15.0M
- FCUV 14.8M
- IPO Year
- AYTU N/A
- FCUV N/A
- Fundamental
- Price
- AYTU $2.24
- FCUV $0.21
- Analyst Decision
- AYTU
- FCUV
- Analyst Count
- AYTU 0
- FCUV 0
- Target Price
- AYTU N/A
- FCUV N/A
- AVG Volume (30 Days)
- AYTU 32.2K
- FCUV 1.0M
- Earning Date
- AYTU 11-12-2024
- FCUV 11-15-2024
- Dividend Yield
- AYTU N/A
- FCUV N/A
- EPS Growth
- AYTU N/A
- FCUV N/A
- EPS
- AYTU N/A
- FCUV N/A
- Revenue
- AYTU $81,002,000.00
- FCUV $839,623.00
- Revenue This Year
- AYTU N/A
- FCUV N/A
- Revenue Next Year
- AYTU N/A
- FCUV N/A
- P/E Ratio
- AYTU N/A
- FCUV N/A
- Revenue Growth
- AYTU N/A
- FCUV 43.94
- 52 Week Low
- AYTU $2.11
- FCUV $0.15
- 52 Week High
- AYTU $3.50
- FCUV $2.38
- Technical
- Relative Strength Index (RSI)
- AYTU 40.89
- FCUV 38.87
- Support Level
- AYTU $2.11
- FCUV $0.20
- Resistance Level
- AYTU $2.44
- FCUV $0.24
- Average True Range (ATR)
- AYTU 0.14
- FCUV 0.03
- MACD
- AYTU -0.02
- FCUV -0.01
- Stochastic Oscillator
- AYTU 17.57
- FCUV 8.73
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. AR101/enzastaurin has received Orphan Drug designation from the FDA. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which it generates maximum revenue from the Rx segment.
About FCUV Focus Universal Inc.
Focus Universal Inc develops and manufactures universal smart devices. Its product portfolio includes Universal Smart Instrumentation Platform, Ubiquitor, Universal Smart Controller, and Sensors. The company also supplies various air filtration systems. The Company consists of three types of operations- Focus and Focus Shenzhen (Corporate), Perfecular and Lusher (IoT Products), and AVX (IoT Installation Services). The majority of revenue is generated from IoT Installation Services. IoT Installation Services segment is an IoT installation and management company specializing in high-performance and easy-to-use audio/video, home theater, lighting control, automation, and integration.